Dr Anthony Holmes
Anthony is a healthcare technology advisor and former CEO of Optasia Medical. After completing his PhD in 2001 with the University of Manchester Imaging Science group in breast cancer detection in mammograms, he joined Image Metrics to help commercialise machine learning algorithms in the healthcare, media and security domains. From 2006 until 2018 he worked at Optasia Medical, applying machine learning to musculoskeletal disease areas and obtaining regulatory clearance in Europe and the USA for medical device software. As CEO from 2013, he invented and managed the development of ASPIRE, a machine-learning powered and CQC-regulated teleradiology service for the diagnosis and referral of osteoporotic vertebral fracture patients, now deployed in several NHS Trusts. Anthony now works with a number of companies and universities, advising them on all aspects of commercialisation of machine learning.
Bridging the gap: how good ideas become great products
Artificial Intelligence is everywhere, or appears to be. Yet whilst it has the potential to make a big difference in healthcare, in truth there are still relatively few genuine AI deployments that genuinely impact patient outcomes. Based on two decades of experience commercialising AI in healthcare, Anthony will provide some ‘do’s and don’ts’ to consider when bringing AI algorithms
to market, including the most important: “Get out of the building!”.
EVEN MORE SEMINARS
Sarah-May Gould King’s College London & Guy’s and St Thomas’ PET Centre
A Review of Attenuation Correction in Positron Emission Tomography
Dr Fred Ushakov University College London Hospital & London School of Ultrasound
Spina bifida: Early diagnosis at 11-13 weeks of pregnancy
Moira Crotty NHS Digital
IT and Informatics Toolkit for Imaging Networks
Dr Mark Halling-Brown Royal Surrey County Hospital
Practicalities of creating medical image research databases for AI
Simon Walker-Samuel University College London
Using medical imaging with machine learning to develop efficient tools for diagnosing cancer